These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 18194980
1. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Kitamura H, Isaka Y, Takabatake Y, Imamura R, Suzuki C, Takahara S, Imai E. Nephrol Dial Transplant; 2008 May; 23(5):1521-8. PubMed ID: 18194980 [Abstract] [Full Text] [Related]
3. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S. Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748 [Abstract] [Full Text] [Related]
10. Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144. Zhou Y, Fang L, Yu Y, Niu J, Jiang L, Cao H, Sun Q, Zen K, Dai C, Yang J. Am J Physiol Renal Physiol; 2016 Jan 01; 310(1):F27-40. PubMed ID: 26469975 [Abstract] [Full Text] [Related]
14. Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases. Fitzgerald JP, Chou SY, Franco I, Mooppan UM, Kim H, Saini R, Gulmi FA. J Urol; 2009 Oct 01; 182(4 Suppl):1860-8. PubMed ID: 19692013 [Abstract] [Full Text] [Related]
15. Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects. Chang YK, Choi DE, Na KR, Lee SJ, Suh KS, Kim SY, Shin YT, Lee KW. J Urol; 2009 Mar 01; 181(3):1434-43. PubMed ID: 19157461 [Abstract] [Full Text] [Related]
17. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, Doni M, Mengozzi M, Tonelli R, Ghezzi P, Coleman T, Brines M, Cerami A, Latini R. Proc Natl Acad Sci U S A; 2005 Feb 08; 102(6):2046-51. PubMed ID: 15671158 [Abstract] [Full Text] [Related]
18. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjørn SE, Gerwien J, Leist M. Thromb Haemost; 2008 Apr 08; 99(4):720-8. PubMed ID: 18392330 [Abstract] [Full Text] [Related]
19. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice. Yoshimi M, Maeyama T, Yamada M, Hamada N, Fukumoto J, Kawaguchi T, Kuwano K, Nakanishi Y. Respirology; 2008 Sep 08; 13(5):639-45. PubMed ID: 18713087 [Abstract] [Full Text] [Related]
20. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo. Robinson Y, Matenov A, Tschöke SK, Weimann A, Oberholzer A, Ertel W, Hostmann A. Acta Anaesthesiol Scand; 2008 May 08; 52(5):605-13. PubMed ID: 18419713 [Abstract] [Full Text] [Related] Page: [Next] [New Search]